Join Senseonics for an in-person and virtual analyst event featuring KOL David T. Ahn, MD (Chief of Diabetes Services, Hoag), who will join company management to discuss the Eversense 365 platform, a continuous glucose monitoring (CGM) device designed to manage and monitor Type 1 and Type 2 diabetes.

The event will review recent milestones and provide a comprehensive update on Eversense 365 commercial progress, including European launch, integration with the Sequel twiist pump, pipeline development activities (including the Gemini and Freedom programs), and clinical data being presented at ADA. Dr. Ahn will also discuss his experience with Eversense 365, including the insertion procedure and patient satisfaction. Senseonics management will provide financial and high-level operation updates.

A live question and answer session will follow the formal presentations.